Dr Chandra Kirana has experience in isolating and identifying bio-active compounds from medicinal plants using various chromatographic techniques and using small animal models to assess efficacy of the active compounds including AOM-induced colon cancer and DSS-induced inflammatory bowel disease model study. Her research interest focus on biomarkers for bowel cancer using proteomic approaches and understanding bowel cancer liver metastasis leading to cancer treatment. Her work equipped with large number of tissue samples from patients complete with clinical parameters including tumour characteristics and patient’s 5 year follow up.
Clinicians at The Queen Elizabeth Hospital and Royal Adelaide Hospital
Mr John Keating, Wellington Hospital, Wellington, New Zealand
Professor Richard Stubbs, P3 Research, Wellington, New Zealand
Dr Lifeng Peng, Centre for Biodiscovery, School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
Dr Andrea Bubendorfer, Callaghan Innovation, New Zealand’s Innovation Agency, Wellington, New Zealand
Cancer Voices SA